Schedule 13G ownership disclosure

Maravai LifeSciences Holdings Inc

Security class unavailable · CUSIP: 56600D107

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,011,179
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006453
Form type
SC 13G/A
Filer
12 West Capital Management LP
CIK
CIK 1540531
Filed
Nov 13, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub